Pharmacists' Impact on Patient Safety

Total Page:16

File Type:pdf, Size:1020Kb

Pharmacists' Impact on Patient Safety AMERICAN PHARMACISTS ASSOCIATION Pharmacists’ Impact on Patient Safety A Joint Project of the American Pharmacists Association Academy of Pharmacy Practice and Management and Academy of Pharmaceutical Research and Science This publication was developed by the American Pharmacists Association. © American Pharmacists Association. All rights reserved. Printed in the U.S.A. Expert Panel Members Chelsea M. Anderson, PharmD, MBA, BCPS—Chair Dorothy L. Smith, PharmD Project Manager CEO and President Center for Medication Safety Advancement Consumer Health Information Corporation Purdue University College of Pharmacy McLean, Virginia West Lafayette, Indiana Terri Warholak, PhD, FAPhA Kimberly Sasser Croley, PharmD, CGP, Associate Professor FASCP, FAPhA The University of Arizona College of Pharmacy Clinical Pharmacist Tucson, Arizona Laurel Senior Living Communities London, Kentucky Daniel A. Zlott, PharmD, BCOP Oncology Pharmacy Specialist Calvin “Clay” Daniels, PharmD, PhD—Observer National Institutes of Health PGY2 Medication Use Safety Resident Bethesda, Maryland St. Jude Children’s Research Hospital Memphis, Tennessee Stefanie P. Ferreri, PharmD, CDE, BCACP, FAPhA Project Coordinator and Director, PGY1 Community Residency Program Contributing Author Clinical Associate Professor and Executive Vice Chair Angela T. Cassano, PharmD, BCPS, FASHP University of North Carolina Eshelman Pharmfusion Consulting, LLC School of Pharmacy Midlothian, Virginia Chapel Hill, North Carolina Elizabeth Flynn, PhD Clinical Associate Affiliate Professor APhA Staff Contributors University of Florida College of Pharmacy Ryan M. Burke, PharmD Artesia, New Mexico Associate Director, Practice Initiatives John A. Galdo, PharmD, BCPS, CGP Anne Burns, BSPharm Assistant Professor Vice President, Professional Affairs Samford University McWhorter School of Pharmacy Birmingham, Alabama Lindsay Kunkle, PharmD Director, Practice and Science Affairs Ashley Lorenzen, PharmD, BCPS Assistant Professor James A. Owen, BSPharm, PharmD, BCPS Concordia University Wisconsin School Vice President, Practice and Science Affairs of Pharmacy Mequon, Wisconsin Margaret Tomecki, PharmD, FAPhA Director, Practice and Science Academies Todd R. Marcy, PharmD, BCPS, CDE, CACP Associate Professor The contributions and significant commitment University of Oklahoma College of Pharmacy of these individuals in the development of this Oklahoma City, Oklahoma publication is gratefully acknowledged and sincerely appreciated. PHARMACISTS’ IMPACT ON PATIENT SAFETY • 1 Background care technologies. Pharmacists use this education and training to prevent medication errors, drug Medications are powerful tools that, if used interactions, and other adverse medication events correctly, can prevent or treat disease. If used from reaching patients. incorrectly, there is potential to cause great harm The safe distribution of medication to patients, to people who take them. These unintended also called dispensing or filling medication or effects, called adverse effects, can occur from prescription orders, remains a core function of any medication. As health care teams, which pharmacy practice. Ensuring the right dose of the include physicians, pharmacists, and other health right drug reaches the right patient at the right care providers, are making decisions about using time by the right route is the minimum standard by specific medications to treat an individual patient, which a pharmacist reviews every medication order they must weigh the potential risks against the for every patient. This practice is known as the “five desired benefit of each medication to minimize the rights”; it focuses pharmacists’ attention on patient chance of harm to the patient. safety and requires pharmacists to thoroughly As important members of the health care team, review each time a prescription or medication pharmacists work collaboratively with patients’ order is dispensed. In addition to the five rights, other health care providers in all types of patient pharmacists have responsibilities to make sure that care settings ranging from community pharmacies patients can get the medication they need and to hospitals and long-term care facilities. Across have the correct information to use the medication these settings, pharmacists take specific actions safely and effectively. that regularly contribute to improving patient With the expanding number and complexity safety. In the United States, a pharmacist is of medications, pharmacists’ roles and required to complete six to eight years of responsibilities have expanded broadly beyond education that includes training about diseases and medication distribution. Pharmacists are providing the medications used to prevent and treat them. patient care in almost all health care settings In addition to training on medications, pharmacist to help people of all ages get the most from education and training includes assessing health the medications that are prescribed to them. status of patients, providing education and Examples of pharmacists’ patient care services counseling, managing diseases, and using health include providing health and wellness screenings, managing chronic diseases, assisting patients with medication management, administering immunizations, and working with hospitals and Ensuring the right dose of the health systems to improve patient care and reduce the number of patients who are readmitted to the right drug reaches the right hospital following their hospital stay. patient at the right time by Pharmacists’ medication distribution and patient care services increase patients’ understanding of the right route is the minimum their medications and contribute to improving patient safety. standard by which a pharmacist reviews every medication order for every patient. 2 • PHARMACISTS’ IMPACT ON PATIENT SAFETY Pharmacists’ Actions to Improve Patient Safety and the Pharmacists contribute to improved Potential Impact patient safety by: As health care providers, pharmacists take an oath • Ensuring medication access: Making that reads, in part, “I will apply my knowledge, sure patients can afford their medications experience, and skills to the best of my ability and get the medications they need to assure optimal outcomes for my patients.”1 • Supplying medication information: Optimal outcomes include the safe use of Sharing information with patients medications resulting in the desired benefit to and their caregivers so they can take the patient’s health. While there are many actions medications safely and effectively that pharmacists can take to fulfill this oath and contribute to optimal outcomes, this publication • Evaluating medication appropriateness: highlights eight specific pharmacist actions that Assessing each medication to be sure improve patient safety within the health care that the medication treatment is the system. These eight actions are routinely taken by most appropriate, effective, and safe pharmacists in daily practice across patient care choice for the individual patient settings. The actions were compiled by an expert • Improving medication adherence: panel of pharmacist leaders and other contributors Helping patients take medications as from a variety of patient care settings. The actions prescribed by their health care providers are not listed in any specific order. For each action, • Providing health and wellness services: example scenarios are provided to illustrate how Delivering needed patient care services pharmacists address specific patient care issues designed to improve the health of through their actions and the outcomes and the patients impact those actions have on patient safety. • Performing medication management services: Comprehensively reviewing all of a patient’s medications, ensuring that they will work together without avoidable problems, and developing an effective, well-designed treatment plan for the treatment or prevention of disease • Assessing patients’ health status: Determining the current status of a patient to provide treatment guidance and assess the effectiveness of medication therapy • Coordinating care transitions: Assisting with care coordination and medication management coordination for patients as they transition from one care setting to another 2 • PHARMACISTS’ IMPACT ON PATIENT SAFETY PHARMACISTS’ IMPACT ON PATIENT SAFETY • 3 Measuring Impact Ensuring Medication Access There are many ways to measure the impact that The costs of health care, particularly those a particular patient care action has on the patient related to medications, can prevent patients from and the health care system. While some measures, achieving their treatment goals. Patients may such as how many days a patient spends in the choose to skip a dose of medication or completely hospital, are quantifiable, others are not. For stop taking a medication due to cost. Since patients, the focus is often on quality of life, the medications are an important part of managing cost of care, or how satisfied they are with the care disease, not taking them can result in patients they receive. In almost every case, pharmacists’ returning to the hospital, which can be very costly actions aimed at improving patient safety result for both the patient and the health care system. in a positive impact to the patient and the health Pharmacists have the knowledge and resources care system. to help patients address medication costs. In cases where insurance coverage is an issue, pharmacists can work directly with the patient’s insurance company to resolve problems.
Recommended publications
  • Strategies to Increase Health Facility Deliveries: Three Case Studies
    Strategies to increase health facility deliveries: Three case studies Strategies to increase health facility deliveries: Three case studies Copyright © 2014 UCSF Global Health Group The Global Health Group Global Health Sciences University of California, San Francisco 550 16th Street, 3rd Floor San Francisco, CA 94158 USA Email: [email protected] Website: globalhealthsciences.ucsf.edu/global-health-group Ordering information This publication is available for electronic download at globalhealthsciences.ucsf.edu/global-health-group/ ghg-publications Recommended citation Butrick, E., Diamond-Smith, N., Beyeler, N., Montagu, D., Sudhinaraset, M. (2014). Strategies to increase health facility deliveries: Three case studies. Global Health Group, Global Health Sciences, University of California, San Francisco. Cover photos courtesy of Photoshare. © 2006 Abhijit Dey (India) and © 2012 Akintunde Akinleye/NURHI (Nigeria). Produced in the United States of America. First Edition, December 2014 This is an open-access document distributed under the terms of the Creative Commons Attribution-Noncommercial License, which permits any noncommercial use, distribution, and repro- duction in any medium, provided the original authors and source are credited. Contents Introduction | 1 Methods | 2 Country selection process | 2 Interviews and recruitment | 2 Description of each case study | 3 Malawi | 3 Nigeria | 3 India | 3 Summary of themes | 4 Lesson learned #1: Political will | 4 Lesson learned #2: Balancing supply, demand and quality | 5 Lesson learned
    [Show full text]
  • Mobile Health Technologies
    Mobile Health Technologies Hemant K. Bhargava Graduate School of Management, University of California, Davis, Davis, California 95616 [email protected] Julia Tanghetti Graduate School of Management, University of California, Davis, Davis, California 95616 [email protected] Abstract Mobile health solutions are expanding rapidly and have become a part of the health care landscape. Over a hundred thousand mobile apps exist today, and create value in very diverse ways. This paper proposed a framework for classifying mHealth solutions on three dimensions, type of technology (form factor), level of institutional integration, and function. It examines the underlying process by which different types of mHealth applications create value, and maps the classification dimensions to potential ways in which these solutions can impact patient health, costs, and other metrics. The optimal choice and design of mHealth technology will depend on patient population characteristics or the settings in which these technologies are deployed. We apply this classification by reviewing a small number of mHealth applications which have been described in the literature. In many cases, the potential impact of such technologies may not be easy to identify, to measure, or to attribute it to the technology. Moreover, while many solutions aim to make patients better informed, this may not necessarily lead to better patient health, because there is evidence in other domains that, when given more information and control, non-experts develop over-confidence, make poorer decisions, and achieve worse outcomes. Today’s computing devices are extremely powerful, small, lightweight and ubiquitous. One such device is the modern smartphone, which carries more processing power than was available to NASA when it landed the first man on the moon in 1960.
    [Show full text]
  • Note on Health Facility and Types Larina Brooklyn * College of Medicine and Health Academy, Nigeria
    Health Econ Outcome Res Open Access 2021, Vol.7, Issue 5, e114. Editorial Note on Health Facility and Types Larina Brooklyn * College of Medicine and Health Academy, Nigeria Corresponding Author* clinics are these days staffed by expertly prepared specialists, attendants, paramedical clinicians, and so forth, though truly, this work was typically Larina Brooklyn done by the establishing strict orders or by volunteers. College of Medicine and Health Academy, Nigeria Medical Care Community E-mail: [email protected] Medical care habitats, including facilities, specialist's workplaces, earnest consideration communities and mobile medical procedure places, Copyright: © 2021 Larina Brooklyn . This is an open-access article distributed fill in as first resource with a health proficient and give outpatient clinical, under the terms of the Creative Commons Attribution License, which permits nursing, dental, and different sorts of care administrations. unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Clinical Nursing Homes Clinical nursing homes, including private therapy places and geriatric Received 18 May 2021; Accepted 20 May 2021; Published 27 May 2021 consideration offices, are medical services foundations which have convenience offices and which take part in giving present moment or long haul clinical therapy of a general or concentrated nature not performed by clinics to inpatients with any of a wide assortment of ailments Introduction Drug Stores and Pharmacies A health facility is, by and large, any area where medical services is Drug stores and pharmacies involve foundations occupied with given. Health offices range from little facilities and specialist's workplaces retailing remedy or nonprescription medications and prescriptions, to dire consideration places and enormous medical clinics with intricate and different kinds of clinical and muscular goods.[4] Regulated drug trauma centers and emergency rooms.
    [Show full text]
  • Operational Considerations for Case Management of COVID-19 in Health Facility and Community Interim Guidance 19 March 2020
    Operational considerations for case management of COVID-19 in health facility and community Interim guidance 19 March 2020 Background This document is intended for health ministers, health system administrators, and other decision-makers. It is meant to guide the care of COVID-19 patients as the response capacity of health systems is challenged; to ensure that COVID-19 patients can access life-saving treatment, without compromising public health objectives and safety of health workers. It promotes two key messages: 1. Key public health interventions regardless of transmission scenario; and 2. Key action steps to be taken by transmission scenario to enable timely surge of clinical operations. The public health objectives at all stages of the preparedness and response plan are to: • Prevent outbreaks, delay spread, slow and stop transmission. • Provide optimized care for all patients, especially the seriously ill. • Minimize the impact of the epidemic on health systems, social services, and economic activity. Based on the largest cohort of COVID-19 patients, about 40% of patients with COVID-19 may have mild disease, where treatment is mostly symptomatic and does not require inpatient care; about 40% of patients have moderate disease that may require inpatient care; 15% of patients will have severe disease that requires oxygen therapy or other inpatient interventions; and about 5% have critical disease that requires mechanical ventilation.1 However, the evolution of the outbreak in some countries has shown a higher proportion of severe and critical cases and the need to rapidly increase surge capacity to prevent rapid exhaustion of biomedical supplies and staff. In some countries, doubling rates of cases every 3 days has been observed.2 Scenarios of transmission Countries or subnational areas will have to respond rapidly to one or more epidemiological scenarios.
    [Show full text]
  • A Model Policy for SMART Health Facilities the Model Policy for SMART Health Facilities Was Prepared by Dr
    A Model Policy for SMART Health Facilities The Model Policy for SMART Health Facilities was prepared by Dr. Vasantha Chase, et al, (Castries, Saint Lucia), on behalf of the Pan American Health Organization (2013). TABLE OF CONTENTS Foreword . 3 Section I – Defining the Problem . 5 • The vulnerability of health facilities to natural hazards . 5 • The vulnerability of health facilities to climate change and variability . 6 • Damage to health facilities from disasters . 7 • The cost of damage to health facilities in the Caribbean . 8 • Costs related to climate change and variability . 9 • Progress is being made . 10 Section II –Conceptual Framework for a Policy on SMART Health Facilities . 13 Section III – A Model for Developing a SMART Health Facilities Policy . 17 • Purpose of the policy . 17 • Policy guidelines . 17 • Components of the policy . 18 • Policy strategy . 21 • Implementing the policy . 22 • Monitoring, evaluation and reporting . 23 Conclusion . 25 Acronyms . 26 Glossary . 27 List of Tables • Table 1: Impact of Hurricane Tomas (2010) on health facilities in Saint Lucia . 7 • Table 2: Categorization of Energy Supply in Health Facilities in Guyana . 10 List of Figures • Figure 1: SMART Health Facilities Policy: The conceptual framework . 14 • Figure 2: Operationalising the SMART Health Facilities Policy . 16 • Figure 3: Mapping the Policy on SMART Health Facilities . 19 1 FOREWORD he Caribbean is a highly hazard-prone region. Hurricanes Gilbert, Ivan and Tomas are stark reminders of how the direct and indirect impact of weather-related disasters can significantly Tdisrupt access to health services and the sector’s ability to provide care. However, today it also is becoming increasingly clear that the health sector itself is one of many contributors to the impact of climate change, making it imperative to step up efforts to reduce the environmental footprint and increase the resiliency of its health facilities.
    [Show full text]
  • Interventions to Improve Adherence to Antiretroviral Therapy (ART) in Sub-Saharan Africa: an Updated Systematic Review
    International Journal of Environmental Research and Public Health Review Interventions to Improve Adherence to Antiretroviral Therapy (ART) in Sub-Saharan Africa: An Updated Systematic Review Panmial Priscilla Damulak 1,2 , Suriani Ismail 1,*, Rosliza Abdul Manaf 1 , Salmiah Mohd Said 1 and Oche Agbaji 3 1 Department of Community Health, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Seri Kembangan 43400, Malaysia; [email protected] (P.P.D.); [email protected] (R.A.M.); [email protected] (S.M.S.) 2 Department of Public Health, Faculty of Basic Medical Sciences, Baze University, Abuja, Plot 686, Cadastral Zone C 00, Nigeria 3 AIDS Prevention Initiative in Nigeria, Jos University Teaching Hospital, Jos 2076, Nigeria; [email protected] * Correspondence: [email protected]; Tel.: +60-3-9769-2408 Abstract: Optimal adherence to antiretroviral therapy (ART) remains the bedrock of effective therapy and management of human immunodeficiency virus (HIV). This systematic review examines the effect of interventions in improving ART adherence in sub-Saharan Africa (SSA), which bears the largest global burden of HIV infection. In accordance with PRISMA guidelines, and based on our inclusion and exclusion criteria, PUBMED, MEDLINE, and Google Scholar databases were searched for published studies on ART adherence interventions from 2010 to 2019. Thirty-one eligible studies published between 2010 to 2019 were identified, the categories of interventions were Citation: Damulak, P.P.; Ismail, S.; structural, behavioral, biological, cognitive, and combination. Study characteristics varied across Abdul Manaf, R.; Mohd Said, S.; design, intervention type, intervention setting, country, and outcome measurements. Many of the Agbaji, O.
    [Show full text]
  • Medication Adherence
    ISSUE BRIEF No. 13 MEDICATION ADHERENCE APRIL 2020 ccess to medically necessary healthcare—including prescription A medications—is critical for successful patient outcomes, yet patients’ access to care and treatment are often impeded or blocked entirely by high deductibles, co-pays and coinsurance. These out-of-pocket (OOP) costs hit low-income seniors and individuals with disabilities especially hard, and OOP costs are a key reason why many Medicare beneficiaries do not initiate or adhere to treatment. However, other factors also play a role in preventing people from adhering to the medications prescribed by their healthcare providers. This Issue Brief examines why some patients do not adhere to their prescription medications, how non-adherence impacts these patients, and strategies that have been proposed to improve medication adherence. The PAN Foundation believes that out-of-pocket costs should not prevent individuals with life-threatening, chronic and rare diseases from obtaining their prescribed medications. 2 What is Medication Adherence? Medication adherence is the extent to which patients take their medications correctly as prescribed by their healthcare providers.1 When people adhere to their prescribed medications, they take their medications: • In the right dose • At the right time • In the right way • With the right frequency Medication adherence is important because the risks of worsening health, hospitalization, and death increase when patients don’t adhere to their prescribed medications.2 Factors Contributing to Non-adherence Non-adherence to prescribed medications may stem from one or more of the following reasons: • Lack of transportation to and from a healthcare provider’s office. • Lack of transportation to and from the pharmacy to drop off prescriptions and pick up medications.
    [Show full text]
  • Choosing Hospice Consumer's Guide
    Choosing Hospice a consumer’s guide Table of Contents Introduction ............................................................2 What makes hospice care special? .........................4 Minnesota Network of Hospice & Palliative Care (MNHPC) promotes quality of life in Minnesota How will hospice care provide support communities through education and access to resources in advance care planning, palliative for me and my family? ...........................................6 care and hospice care. What if I live alone or don’t have Our vision is that all individuals, families and family nearby? .......................................................7 providers will understand the value of and have access to these resources. Who is eligible for hospice care? ...........................8 With provider members across Minnesota, the work of MNHPC touches communities through- How is my care paid for? .......................................8 out the entire state. How do I find a hospice program? .......................10 Glossary ...............................................................12 Originally written in 1997 with a grant from the Allina Foundation as part of its Project DECIDE Program. © 1997 Minnesota Hospice Organization. All rights reserved. © 2nd Edition, Revised 1998. All rights reserved. © 3rd Edition, Revised 2000. All rights reserved. © 4th Edition, Revised 2009. All rights reserved. © 5th Edition, Revised 2010. All rights reserved. Made accessible in 2016 by funding from a Live Well at Home Grant from Minnesota Department of Human Services. 1 INTRODUCTION The thought that you or someone you love According to the wife of a hospice patient, is dying can be overwhelming. It may seem “Thank you for being “We knew that Mark’s prognosis wasn’t that all is hopeless, that there is nothing honest with me, for good, but we also knew that we had today more you can do.
    [Show full text]
  • 4 Isolation Rooms
    4 Isolation Rooms 4 Isolation Rooms 4.1 General An isolation facility aims to control the airflow in the room so that the number of airborne infectious particles is reduced to a level that ensures cross-infection of other people within a healthcare facility is highly unlikely. This may be achieved by: . Control of the quantity and quality of intake or exhaust air. Maintain different air pressures between adjacent areas. Designing airflow patterns for specific clinical procedures. Diluting infectious particles with large air volumes. Air filtration – HEPA filters, etc. Isolation facilities include the following types: . Neutral or standard room air pressure, for example standard air conditioning, also known as Class S . Positive room air pressure where an immune-compromised patient is protected from airborne transmission of any infection, Class P . Negative room air pressure, where others are protected from any airborne transmission from a patient who may be an infection risk, Class N . Negative room air pressure with additional barriers including an Anteroom, also known as Class Q for quarantine isolation. Isolation rooms have fairly high rates of air exchange relative to other patient areas. This applies to both ventilation air supply and exhaust flow rates. Potential draughts within the patient room can result, therefore thermal comfort of the patient needs special attention. Consideration should be given to installing individual thermostats in each room so that air temperature and relative humidity can be controlled from within the room. Isolation rooms do not necessarily always require the provision of an Anteroom. This should be determined by the proposed operational policy and be included at an early stage of the design process.
    [Show full text]
  • Checklist to Prepare Physician Offices for COVID-19
    Checklist to Prepare Physician Offices for COVID-19 ASSUMPTION: Transmission will be primarily through exposure to respiratory droplets and direct contact with patients and their contaminated environments. Universal Early Preparation within six feet of patients with suspected COVID-19 infection. (See approved respirators). Provide training ☐ Educate staff and patients about changes they for staff on respirators to ensure fit and appropriate can expect to be implemented in the office use. during an outbreak or pandemic, and about ways to prepare themselves and their families. • Ensure adherence to standard precautions, including airborne precautions and use of eye protection. Assume that every patient is potentially infected or COVID-19 Education colonized with a pathogen that could be transmitted in • Educate staff about coronavirus disease 2019 a health care setting. (COVID-19), and why it is important to contain the • Implement mechanisms and policies that promptly outbreak. alert key facility staff including infection control, health • Educate staff on facility policies and practices care epidemiology, facility leadership, occupational to minimize chance of exposure to respiratory health, clinical laboratory, and frontline staff about pathogens including SARS-CoV-2, the virus that known suspected COVID-19 patients (i.e. PUI). Keep causes COVID-19. updated lists of staff and patients to identify those at risk in the event of an exposure. • Train and educate staff with job-or task-specific information on preventing transmission of infectious • Staff should follow the CDC guidelines collecting, agents, including refresher training. handling and testing clinical specimens from (PUIs for COVID-19. • Educate staff about COVID-19 evaluation and treatment. • Prepare for office staff illness, absences, and/or quarantine.
    [Show full text]
  • Health Facility Checklist Section 1226 [Oshpd 3] Clinics 1226.6 Primary
    Compliance Checklist: [OSHPD 3] Primary Care Clinics Page 1 of 11 HEALTH FACILITY CHECKLIST SECTION 1226 [OSHPD 3] CLINICS 1226.6 PRIMARY CARE CLINICS Primary Care Clinics are Health Facilities licensed under Section 1200 of the California Health & Safety Code that provide services limited to those listed in California Building Code Section 1226.6. Outpatient clinical services of a hospital providing services, licensed under Section 1250 of the California Health & Safety Code, which are equivalent to a primary care clinic, shall also comply with California Building Code Section 1226.6 and be considered a primary care clinic. Primary care clinics are subject to the provisions of Section 1226 [OSHPD 3] CLINICS, of the California Building Code and all amendments to the California Building Standards Code (CBSC) under the banner [OSHPD 3]. OSHPD requirements apply to all facilities described above and are not dependent upon Occupancy Group designations. While Examination Rooms are required in Primary Care Clinics, the provision of Treatment Rooms is optional and dependent upon the intended delivery of care. Examination Rooms are intended for diagnostic examinations, where Treatment Rooms are intended for clinical/interventional procedures and include appropriate size and finish requirements to accommodate treatment/procedures that do not require a restricted (sterile) environment but may use sterile instruments or equipment. All new buildings and additions, alterations or repairs to existing buildings, and conversion of space to a clinic use within existing buildings, subject to Licensing and Certification, California Department of Public Health, shall comply with applicable provisions of the California Building Code (CBC), California Electrical Code (CEC), California Mechanical Code (CMC), California Plumbing Code (CPC), California Energy Code, California Green Building Standards Code and California Fire Code (Parts 2, 3, 4, 5, 6, 9, and 11 of Title 24).
    [Show full text]
  • Operational Considerations for Community Isolation Centers for COVID-19 in Low-Resource Settings
    Operational Considerations for Community Isolation Centers for COVID-19 in Low-Resource Settings Accessible version: https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/operational-considerations-isolation-centers.html Background The coronavirus disease 2019 (COVID-19) pandemic has presented numerous challenges to health systems, including large numbers of patients that can overwhelm health facilities and staff. Community isolation centers (CICs) can give people experiencing mild to moderate symptoms (e.g. fever, fatigue, cough, muscle pain, sore threat, new loss of smell or taste, nasal congestion, shortness of breath or headache) a safe place to voluntarily isolate, while conserving healthcare facility resources. Guiding principles: • Community isolation centers generally do not care for severely ill patients or those with increased risk for severe disease. These patients should seek care at a health facility or hospital where advanced care, treatment and constant monitoring can be provided. However, in cases where no hospital beds are available, CICs can accept such people when feasible to prevent household transmission that could occur if they stayed home. CICs also support linkage to higher level care. • People with mild or moderate illness who have been tested and are waiting for their results should isolate at home until they know their status to avoid becoming infected by other patients at a CIC. In cases where safely isolating at home is not possible, people waiting for results may isolate in a CIC. This document gives operational considerations for CDC country offices, ministries of health, and other partners about establishing and operating CICs for people with suspected or laboratory-confirmed COVID-19.
    [Show full text]